<p>BERWYN, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases today anno
Gold gains remain limited going into the year-end Amid thinner market conditions, gold doesn't much to work with as the year winds down as buyers are finding it tough to build further momentum af
Leave a Comment